The "Bioadaptor" vs. Traditional DES
A major clinical shift in 2026 is the adoption of the Bioadaptor (e.g., DynamX). Traditional DES are rigid; they provide radial strength but freeze the artery in a fixed position.
The Bioadaptor is a hybrid: it provides the initial strength of a metallic stent for the first six months, but once its biodegradable polymer dissolves, its "helical" struts unlock.
This "unlocking" restores natural pulsatility—the artery’s ability to expand and contract with the heartbeat. Data from 2026 shows this significantly improves long-term outcomes for younger patients, as it prevents the late-stage vessel stiffening that often leads to secondary heart attacks in traditional stent recipients
ดู 1 ครั้ง